Financial Data and Key Metrics Changes - For Q4 2025, adjusted EBITDA was $191.1 million, up 54.1% from Q4 2024 and up 2.8% sequentially from Q3 2025 [4] - Net income attributable to ARLP in Q4 2025 was $82.7 million, or $0.64 per unit, compared to $16.3 million, or $0.12 per unit, in Q4 2024 [4] - Total revenues were $535.5 million in Q4 2025, down from $590.1 million in Q4 2024, primarily due to lower coal sales and transportation revenues [5] Business Line Data and Key Metrics Changes - Average coal sales price per ton for Q4 2025 was $57.57, a 4% decrease year-over-year and a 2.1% decrease sequentially [6] - Total coal production in Q4 2025 was 8.2 million tons, compared to 6.9 million tons in Q4 2024 [6] - In the Illinois Basin, coal sales volumes were 6.5 million tons in Q4 2025, down approximately 2% compared to both Q4 2024 and Q3 2025 [7] - In Appalachia, coal sales volumes were 1.7 million tons in Q4 2025, down from 1.8 million tons in Q4 2024 [8] Market Data and Key Metrics Changes - The oil and gas royalty segment achieved total revenue of $56.8 million in Q4 2025, up 17.2% year-over-year [11] - BOE volumes increased 20.2% year-over-year and 10% sequentially in Q4 2025 [11] - Total liquidity as of December 31, 2025, was $518.5 million, including $71.2 million in cash [13] Company Strategy and Development Direction - The company anticipates overall coal sales volumes for 2026 to increase to 33.75 million tons - 35.25 million tons, despite reduced sales volumes at the Mettiki Mine [14] - Contracting activity for 2026 is robust, with over 93% of expected volumes already committed and priced [14] - The company remains committed to investing in its oil and gas royalties business and pursuing disciplined growth in this segment [17] Management's Comments on Operating Environment and Future Outlook - Management highlighted strong contracting activity and a favorable supply-demand dynamic as utilities opt for longer-term agreements [19] - The company noted that coal's value to the grid is increasingly recognized, especially during extreme weather events [26] - Management expects demand growth driven by data centers and industrial development, which will support coal pricing [25] Other Important Information - The company ended Q4 2025 with 1.1 million tons of coal inventory, an increase compared to previous quarters [10] - The anticipated impact of reduced sales volumes at Mettiki is reflected in the 2026 guidance, with potential impairment evaluations planned for Q1 2026 [10] Q&A Session Summary Question: What does it take to get to the high or low end of your price per ton guidance? - Management indicated that most remaining tons to be sold are in the Illinois Basin, with potential upside depending on customer contract flexibilities [34] Question: What would it take for Alliance to increase production? - Management stated that no new units are planned, but productivity improvements are expected to drive growth [40] Question: Any thoughts on modeling equity method investments going forward? - Management suggested a lower run rate of around $3 million per quarter for equity investment income moving forward [43] Question: How should we think about quarterly sales cadence in 2026? - Management expects Q1 2026 to be the lowest sales quarter, with gradual improvement anticipated in subsequent quarters [49] Question: How do you expect export sales to compare to 2025 levels? - Management noted that export sales are limited, focusing primarily on domestic customers due to higher netbacks [51]

Core Viewpoint - The article highlights the performance forecast of various A-share listed companies, indicating a significant divergence in earnings growth across different sectors, driven by technological advancements, cost control, and industry cycles [4][62]. Group 1: Companies with Strong Earnings Growth - **New Yisheng (300502.SZ)**: Expected net profit of 9.4 billion to 9.9 billion, a year-on-year increase of 231.24% to 248.86%, driven by rising demand for high-speed optical modules due to global computing power investments [6]. - **Han's Laser (688256.SH)**: Expected net profit of 1.85 billion to 2.15 billion, turning from a loss of 0.452 billion in the previous year, benefiting from the increasing demand for AI computing power [8]. - **Zhongji Xuchuang (300308.SZ)**: Expected net profit of 9.8 billion to 11.8 billion, a year-on-year increase of 89.50% to 128.17%, supported by strong investment in computing infrastructure [10]. - **Runze Technology (300442.SZ)**: Expected net profit of 5 billion to 5.3 billion, a year-on-year increase of 179.28% to 196.03%, primarily due to non-recurring gains from public REITs issuance [12]. - **CITIC Securities (601995.SH)**: Expected net profit of 8.542 billion to 10.535 billion, a year-on-year increase of 50% to 85%, driven by steady growth in core business segments [15]. Group 2: Companies with Earnings Below Expectations - **Great Wall Motors (601633.SH)**: Expected net profit of 9.912 billion, a year-on-year decrease of 21.71%, impacted by increased marketing expenses and intense competition [34]. - **GAC Group (601238.SH)**: Expected net profit of -8 billion to -9 billion, turning from a profit of 0.824 billion in the previous year, due to fierce competition and adjustments in product structure [36]. - **GCL-Poly Energy (002506.SZ)**: Expected net profit of -0.89 billion to -1.29 billion, turning from a profit of 0.068 billion, affected by structural supply-demand issues in the photovoltaic industry [38]. - **Boli Tianheng (688506.SH)**: Expected net profit of -1.1 billion, turning from a profit of 3.708 billion, due to increased R&D expenses [39]. - **Daiyue City (000031.SZ)**: Expected net profit of -2.7 billion to -2.1 billion, continuing losses from the previous year, influenced by asset impairment provisions [42]. Group 3: Industry Trends - **Technological Breakthroughs**: Industries driven by technology, such as AI and innovative pharmaceuticals, are showing strong growth, with companies like New Yisheng and Rongchang Bio leading the way [62][63]. - **Cost Control**: The energy and manufacturing sectors are experiencing a clear divide, with companies like Datang Power benefiting from lower coal prices and effective cost management [64]. - **Downward Pressure from Industry Cycles**: The real estate, agriculture, and photovoltaic sectors are under significant pressure, with companies like Vanke and Tianbang Food facing substantial earnings declines [65][66].

智通财经记者 | 周姝祺 2026年伊始，中国车市需求复苏乏力，汽车公司仍深陷以价换量的泥潭之中。而在远离展厅的供应链深处，一场更具杀伤力的成本风暴在同步酝酿。铜、 铝、碳酸锂等关键原材料与存储芯片价格齐涨，正进一步挤压本就微薄的利润空间，让汽车制造这门生意变得愈发艰难。 根据瑞银投资银行向智通财经提供的研报数据，受2026年初刺激措施退坡、购置税恢复与大宗商品成本上涨的三重挑战冲击，预计一辆普通的中型智能化电 动汽车的成本涨幅高达4000至7000元。 在大多数成熟工业行业，大幅度的成本上涨通常会转嫁至终端售价。但在竞争淘汰出清、需求偏弱的当下中国电动汽车市场，涨价几乎等同于让出份额。整 车厂或被迫自行消化成本，或层层转嫁至上游供应商。在利润和现金流之间，一场围绕成本控制的博弈正在全行业展开。 汽车公司本轮承受的成本上涨，并不完全来自熟悉的矿山等上游资源端，而是被人工智能爆发引发的算力和数据中心需求外溢所推高。富国银行在研究报告 中指出，数据中心和人工智能应用需求激增，正推高全球存储芯片供需缺口，汽车制造商面临新的成本压力和潜在的供应中断风险。 对于整车企业而言，存储芯片早已成为智能汽车的底层配置，广泛嵌入 ...

Financial Data and Key Metrics Changes - Consolidated revenue for the fourth quarter was $973 million, down 3% year-over-year [14] - Non-GAAP operating income from continuing operations was $14 million, compared to $41 million last year [14] - Adjusted non-GAAP earnings per share were $0.36, down from $1.33 in the fourth quarter of 2024 [14] Business Line Data and Key Metrics Changes - Asset-Based LTL shipments increased 2% year-over-year, averaging about 20,000 shipments per day [7] - Revenue for the Asset-Based segment was $649 million, flat on a per-day basis [15] - Asset-Light segment revenue was $354 million, a daily decrease of 5% year-over-year [17] - Non-GAAP operating results for Asset-Light were break-even for the quarter, an improvement from a $17 million loss in 2024 [18] Market Data and Key Metrics Changes - Daily shipments in January increased 3% year-over-year, with weight per shipment increasing 5% [16] - In January, Asset-Light daily revenue increased 6% year-over-year, with shipment growth of 13% led by Managed Solutions [19] Company Strategy and Development Direction - The company focuses on three pillars: growth, efficiency, and innovation, aiming to deliver premium service and maintain a customer-first mindset [5][6] - The company is advancing initiatives outlined at the Investor Day to achieve long-term targets and deliver greater shareholder value [6] - Investments in technology and optimization projects are expected to enhance operational efficiency and customer service [10][12] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the ongoing freight recession and market volatility but expressed confidence in the company's strategic direction and ability to navigate challenges [5][20] - The company anticipates a typical seasonal increase in operating ratio but expects it to be better than historical averages due to a softer fourth quarter [17] - Management remains focused on maintaining yield discipline and managing costs to position the company for sustainable long-term profitability [20] Other Important Information - The company welcomed new independent directors to strengthen its board [7] - The company returned over $86 million to shareholders through share repurchases and dividends in 2025 [22] - The balance sheet remains strong with approximately $400 million in available liquidity [22] Q&A Session Questions and Answers Question: Follow-up on January trends and tonnage - Management noted that January was impacted by strong winter storms, affecting shipment dynamics and tonnage levels [25][27] Question: Mix normalization and competitive dynamics - Management indicated that the mix of business has been influenced by the ongoing freight recession and that they are focused on managing profitability [32][33] Question: January trends and industry-wide dynamics - Management clarified that January trends were influenced by specific dynamics within the company, but the overall industry is experiencing similar weather impacts [38] Question: Competitive pricing environment - Management stated that pricing discipline remains rational in the market, with less bid activity from customers being a positive sign [85] Question: Insights from new COO on Asset-Light business - The new COO expressed confidence in the growth of the Asset-Light business and the company's strong foundation in Managed Solutions [88]

香 港 交 易 及 結 算 所 有 限 公 司 及 香 港 聯 合 交 易 所 有 限 公 司 對 本 公 告 之 內 容 概 不 負 責，對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或 任何部份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 Link Holdings Limited 華 星 控 股 有 限 公 司* （於開曼群島註冊成立之有限公司） （股份代號：8237） 有關實施行動計劃以解決不發表意見之季度更新 茲提述(i)華星控股有限公司（「本公司」）於二零二五年四月七日刊發之截至二零二 四年十二月三十一日止財政年度之年報（「二零二四年年報」）；(ii)本公司日期為二 零二五年七月三十日及二零二五年十月三十一日的公告，內容有關（ 其中包括 ）實 施 行動 計劃 以 解決 不發 表意 見 之季 度更 新 ；及 (iii) 本 公司 日期 為 二零 二四 年 十二 月十二日、二零二五年八月五日、二零二五年九月五日及二零二五年十月三十一 日的公告，內容有關（ 其中包括 ）違反經修訂及重列融資協議以及Silverine 提交申 請委任其共同及各別清盤人（ 統稱「該等公告」）。除 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 Hidili Industry International Development Limited 本公告乃由恒鼎實業國際發展有限公司（「本公司」）根據香港聯合交易所有限公司證券上 市規則（「上市規則」）第13.09(1)條以及香港法例第571章證券及期貨條例第XIVA部之內幕 消息條文（定義見上市規則）而作出。 茲提述本公司於二零二五年四月三十日發佈截至二零二四年十二月三十一日止年度的年 報（「年報」）及本公司日期為二零二五年七月三十一日及二零二五年十月三十一日的公告 （「更新公告」）。除文義另有所指外，本公告所用詞彙與年報及更新公告所界定者具有相 同涵義。 誠如年報所述，中匯安達對本集團截至二零二四年十二月三十一日止年度的合併財務報 表出具不發表意見的聲明，該聲明完全源於本集團的持續經營問題。 本公司已於更新公告內就行動計劃的實施情況提供更新，本公告旨在向本公司股東及潛 在投資者提供有關自二零二五年 ...

Group 1 - The company expects to achieve a positive net profit for the fiscal year 2025, indicating a turnaround from previous losses [2][3] - The performance forecast period is from January 1, 2025, to December 31, 2025 [1] - The company has communicated with its accounting firm regarding the performance forecast, and there are no discrepancies between the company and the accounting firm [2] Group 2 - The significant improvement in overall performance is attributed to multiple factors, including support from national industrial policies and an improved supply-demand balance, leading to a rise in domestic rare earth product prices [3] - The company has effectively utilized its advantages in resource efficiency, cost control, and production processes to respond quickly to market changes, resulting in stable development and benefit release in the rare earth resource utilization sector [3] - The strategic layout in the rare earth permanent magnet materials industry has made solid progress, extending into high-value-added downstream sectors, driven by strong demand from end markets such as new energy vehicles, energy-saving appliances, and intelligent manufacturing [3]

Financial Data and Key Metrics Changes - Revenue for Q3 of fiscal 2026 was $556 million, down slightly from the prior year, reflecting lower wallboard and paperboard sales volume, partially offset by higher cement sales volume [11] - Earnings per share were $3.22, down 10% from Q3 of fiscal 2025, primarily due to lower net earnings from wallboard sales volume [11] - Gross profit margin was 28.9%, indicating a stable profitability level despite market challenges [3] Business Line Data and Key Metrics Changes - Heavy materials sector revenue increased by 11%, driven by a 9% increase in cement sales volume and a 22% increase in concrete and aggregates revenue [11] - Aggregate sales volume reached a record 1.6 million tons, up 81%, reflecting a 34% increase in organic aggregate sales volume [13] - Light materials sector revenue decreased by 16% to $203 million, primarily due to lower wallboard and recycled paperboard sales volume [11] Market Data and Key Metrics Changes - Cement and aggregate sales volumes grew last quarter, supported by federal, state, and local infrastructure spending [8] - Wallboard sales were challenged due to affordability issues in the housing market, with a 5% decline in wallboard sales prices [11][9] - The company announced price increases for cement in most markets for Q1 of calendar 2026, reflecting volume expectations [9] Company Strategy and Development Direction - The company aims to maintain operational flexibility and efficiency through investments in health and safety, cost control, and customer support [3][4] - Strategic projects include the modernization of the Mountain Cement plant and the Duke wallboard facility, expected to lower cost structures and enhance competitive positioning [7] - The company is focused on maintaining a strong balance sheet while pursuing growth opportunities through disciplined capital allocation [10] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about infrastructure and non-residential markets as they head into calendar 2026, despite mixed construction environments [19] - The company remains focused on operations rather than predicting demand, emphasizing their ability to manage costs effectively [9] - Management noted that while wallboard pricing has seen some downward trends, they expect stability in pricing due to structural changes in the industry [26] Other Important Information - Operating cash flow increased by 5% to $512 million, with capital spending rising to $295 million, primarily for modernization projects [14] - The company returned nearly $150 million to shareholders through dividends and share repurchases during Q3 [10] - The net debt-to-cap ratio was 48%, with a leverage ratio of 1.8x, providing significant financial flexibility [15] Q&A Session Summary Question: Is cement demand widespread across markets? - Management indicated that demand is broad-based across markets, with optimism for infrastructure and non-residential markets as they enter calendar 2026 [19] Question: What is driving the margins in cement? - Margins were impacted by slight increases in raw material costs, but maintenance and fuel costs remained largely in line [22] Question: How is wallboard pricing expected to trend? - Wallboard pricing has seen a downward trend, but management expects prices to remain range-bound due to structural changes in the industry [26] Question: What is the impact of winter storms on operations? - The company has prepared facilities for extreme cold temperatures, ensuring operations are ready for winter storms [41] Question: What portion of wallboard demand is from repair and remodel? - Repair and remodel account for about a third of wallboard demand, showing steady growth over the years [38] Question: How is the company managing capital allocation post-bond deal? - The company is focused on balancing growth through M&A and organic projects while maintaining a disciplined approach to capital allocation [51]

专题：为中国经济点赞——企业家之夜2025盛典 "为中国经济点赞——企业家之夜"于1月29日在北京举行，北京泛太平洋集团董事长刘持金在对话中表 示，2025年最大的惊喜是地缘政治形势非常有利于中国的国际地位，不少企业、包括中小企业的出海都 迈出了实质性一步，这一点感受最为深切。 对于2026年，他表示充满希望，建议企业家重点关注客户与成本，重视成本控制，这对高质量发展尤为 重要。 专题：为中国经济点赞——企业家之夜2025盛典 "为中国经济点赞——企业家之夜"于1月29日在北京举行，北京泛太平洋集团董事长刘持金在对话中表 示，2025年最大的惊喜是地缘政治形势非常有利于中国的国际地位，不少企业、包括中小企业的出海都 迈出了实质性一步，这一点感受最为深切。 对于2026年，他表示充满希望，建议企业家重点关注客户与成本，重视成本控制，这对高质量发展尤为 重要。 责任编辑：李铁民 责任编辑：李铁民 ...

Financial Data and Key Metrics Changes - Revenue for the nine-month period was just over JPY 3.4 trillion, a decrease of 3.3% or -2.8% at constant exchange rate [11] - Core Operating Profit was JPY 971.6 billion, a year-on-year decrease of 3.4% at both actual effects and constant exchange rate [11] - Reported operating profit was JPY 422.4 billion, an increase of 1.2% [12] - Core EPS was JPY 428, and reported EPS was JPY 137 [12] - Adjusted free cash flow was JPY 625.9 billion, even after a $1.2 billion upfront payment to Innovent Biologics [12] Business Line Data and Key Metrics Changes - Growth and launch products represented over 50% of total revenue and grew 6.7% at constant exchange rate [12] - In GI, Entyvio grew 7.4% at constant exchange rate, with strong growth in Q3 due to a one-time gross-to-net drop [12][13] - Takhzyro in rare diseases slowed to 2.4% growth at constant exchange rate, impacted by new competing products in the U.S. [13] - Immunoglobulin growth was 4.3% year to date, driven by subcutaneous IG products [14] - Qdenga growth accelerated to 22.1%, primarily driven by Brazil [14] Market Data and Key Metrics Changes - Entyvio Pen is now on the formulary with all three large pharmacy benefit managers, achieving commercial coverage of more than 80% [13] - The impact of Medicare Part D redesign in the U.S. has affected IVIG sales, which are expected to normalize in Q4 [14] - Albumin growth returned to 1.3%, slower than expected due to softening demand in China [14] Company Strategy and Development Direction - The company is preparing for significant new product launches, focusing on oveporexton, rusfertide, and zasocitinib, expected to launch over the next 18 months [6][9] - The late-stage pipeline includes eight programs with the potential to transform the standard of care [10] - The company is committed to maintaining operational efficiency while investing in R&D for future growth [17] Management's Comments on Operating Environment and Future Outlook - Management revised revenue guidance to low single-digit decline at constant exchange rate due to stronger than anticipated Vyvanse generic erosion [18] - The company maintains full-year guidance for core operating profit and core EPS, emphasizing cost discipline [18] - Management expressed confidence in the potential of new product launches to drive future growth despite current challenges [20][41] Other Important Information - This earnings call marked Christophe Weber's last as a main presenter, with Julie Kim set to take over as CEO [29] - The company is undergoing organizational changes to enhance competitiveness and speed in preparation for multiple launches [31][55] Q&A Session Summary Question: Thoughts on next fiscal year and dividend policy - Management indicated it is too early to provide guidance for the next fiscal year, with the budget being finalized [39] - The company aims to maintain a progressive dividend policy, evaluating core EPS and cash flow to decide on potential increases [42] Question: Zasocitinib phase II outcomes and safety data - Data from UC and Crohn's disease phase II studies are expected this year, with ongoing studies assessing higher doses for efficacy [44][46] Question: Impact of MFN and organizational changes - Management does not support MFN, emphasizing that price controls could hinder future innovation [53] - Organizational changes focus on enhancing U.S. marketing and maintaining a strong oncology business unit [55] Question: Entyvio sales trends and IRA impact - Q3 sales performance was strong, with improved coverage in the U.S. [60] - The company is preparing for potential price negotiations under the IRA, with uncertainty regarding the extent of price cuts [62][63] Question: Takhzyro growth and competitive impact - Takhzyro continues to be the gold standard for HAE patients, but recent competitive entrants have impacted new starts [67] - Long-term efficacy data supports Takhzyro's market position despite current challenges [68]